Twelve-Week Colostrum Bovinum Supplementation Supports Aerobic Capacity but has No Effect on Body Composition in Endurance-Trained Males: A Randomized Placebo-Controlled Crossover Study

为期十二周的牛初乳补充剂可提高耐力训练男性的有氧能力,但对身体成分无影响:一项随机安慰剂对照交叉研究

阅读:2

Abstract

Twenty-eight endurance-trained males aged 31.1 ± 10.2 years (body mass [BM] 81.9 ± 9.0 kg) completed this randomized double-blind placebo (PLA)-controlled crossover study investigating the effect of 12-week Colostrum Bovinum (COL) supplementation (25g(COL)·day(-1)) on aerobic fitness and capacity, time to exhaustion, BM and body composition (BC), and blood lactate concentration. There were four main-before/after supplementation study visits (COL(PRE) and COL(POST); PLA(PRE), and PLA(POST)). During study visits, BM and BC evaluation, incremental rowing test (IRT) to exhaustion, and evaluation of resting (REST) and post-exercise (POST-IRT) blood lactate concentration were performed. COL, but not PLA supplementation, significantly increased (p < 0.05) time to ventilatory threshold (T(VT)). Moreover, the implemented treatments had large (mL·min(-1)) and moderate (mL·min(-1)·kg(-1)) effects on oxygen uptake at VT (VO(2VT)), as well as moderate effect on power output at VT (P(VT); W·kg(-1)) with the highest values observed at COL(POST) visit. Neither significant influence of COL supplementation on time to exhaustion (T(EXH)) in IRT, BM, and BC on blood lactate was observed. Importantly, there were significantly (p < 0.05) higher increases in VO(2VT) (mL·min(-1) and mL·min(-1)·kg(-1)) after COL compared to PLA supplementation. In summary, COL supplementation resulted in a favorable increase in T(VT), and tended to improve some of the evaluated threshold indicators, namely VO(2VT) and P(VT) in endurance-trained male athletes during IRT. Therefore, COL supplementation may be considered as a support to improve aerobic fitness and capacity in endurance-trained males; however, supplementation strategy must be personalized and properly incorporated into the individual training. TRIAL REGISTRATION: The study protocol was registered at ClinicalTrials.gov (NCT06390670).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。